Abstract
Proteinuria is a widely used marker of renal disease and is strongly associated with renal and cardiovascular outcomes. The molecular mechanisms underlying filtration of serum proteins through the glomerular filtration barrier (GFB) remain to be determined. Since the GFB is a complex structure, studies of albumin or IgG trafficking in cultured cells in vitro may not fully recapitulate these processes in vivo. In other epithelial cells including renal proximal tubular cells, the neonatal Fc receptor (FcRn) is required to divert albumin and IgG from the degradative pathway which allows these proteins to be recycled or transcytosed. To examine the role of podocyte FcRn in albumin and IgG trafficking in vivo, we detail the creation of a podocyte-specific FcRn knockout mouse and describe methods for examining intraglomerular detection of albumin and IgG in these mice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bakris GL (2008) Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol 3:S3–S10
Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303:423–429
Scott RP, Quaggin SE (2015) Review series: the cell biology of renal filtration. J Cell Biol 209:199–210
Peti-Peterdi J (2009) Independent two-photon measurements of albumin GSC give low values. Am J Physiol Ren Physiol 296:F1255–F1257
Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, Brown D, Molitoris BA, Comper WD (2007) The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 71:504–513
Castrop H, Schiessl IM (2016) Novel routes of albumin passage across the glomerular filtration barrier. Acta Physiol (Oxford, England) 219(3):544–553
Kuo T, Baker K, Yoshida M, Qiao S-W, Aveson V, Lencer W, Blumberg R (2010) Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol 30:777–789
Dickinson BL (2016) Unraveling the immunopathogenesis of glomerular disease. Clin Immunol 169:89–97
Andersen JT, Sandlie I (2009) The Versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics. Drug Metab Pharmacokinet 24:318–332
Chaudhury C, Mehnaz S, Robinson JM, Hayton WL, Pearl DK, Roopenian DC, Anderson CL (2003) The major histocompatibility complex–related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197:315–322
Kim J, Bronson CL, Hayton WL, Radmacher MD, Roopenian DC, Robinson JM, Anderson CL (2006) Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces. Am J Physiol Gastrointest Liver Physiol 290:G352–G360
Tenten V, Menzel S, Kunter U, Sicking E-M, van Roeyen CRC, Sanden SK, Kaldenbach M, Boor P, Fuss A, Uhlig S, Lanzmich R, Willemsen B, Dijkman H, Grepl M, Wild K, Kriz W, Smeets B, Floege J, Moeller MJ (2013) Albumin is recycled from the primary urine by tubular transcytosis. J Am Soc Nephrol 24(12):1966–1980
Akilesh S, Huber TB, Wu H, Wang G, Br H, Kopp JB, Miner JH, Roopenian DC, Unanue ER, Shaw AS (2008) Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci USA 105:967–972
Roopenian DC, Christianson GJ, Sproule TJ, Brown AC, Akilesh S, Jung N, Petkova S, Avanessian L, Choi EY, Shaffer DJ, Eden PA, Anderson CL (2003) The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol 170:3528–3533
Montoyo HP, Vaccaro C, Hafner M, Ober RJ, Mueller W, Ward ES (2009) Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice. Proc Natl Acad Sci 106:2788–2793
Dylewski J, Dobrinskikh E, Lewis L, Tonsawan P, Miyazaki M, Jat PS, Blaine J (2019) Differential trafficking of albumin and IgG facilitated by the neonatal Fc receptor in podocytes in vitro and in vivo. PLoS One 14:e0209732
Acknowledgments
This work was funded by a Norman Coplon Satellite Healthcare grant and NIH R01DK104264 to JB.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Blaine, J. (2021). Generating a Podocyte-Specific Neonatal F Receptor (FcRn) Knockout Mouse. In: Singh, S.R., Hoffman, R.M., Singh, A. (eds) Mouse Genetics . Methods in Molecular Biology, vol 2224. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1008-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1008-4_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1007-7
Online ISBN: 978-1-0716-1008-4
eBook Packages: Springer Protocols